
The EU Biotech Act Has Been Delayed — Here's What That Means
By Jackie Mulryne and Eleri Abreo, Arnold & Porter The current EU regulatory landscape for biotechnology is widely viewed as insufficient to be able to exploit the full potential of such technologies. Regulatory hurdles exist at the EU and Member State …